Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, while the global education technology market size is projected to reach $348.41 billion by 2030.
Each week will do a roundup of the top news, fundings, and IPOs from these two sectors.
Top News
- IntelyCare, a technology-enabled healthcare staffing platform, acquired CareRev, an on-demand workforce platform purpose-built for acute care. Both organizations will continue operating under their established brands and services
- Speechify partnered with the New York City Department of Education to make its voice-based accessibility tools available to students across the city’s public school system. Students will be able use the platform on school computers to listen to webpages, PDFs, and homework assignments, as well as on mobile devices to support reading outside the classroom
AI News
- Healthee, an AI-powered health benefits platform, partnered with The Health Benefit Alliance, a provider of customized health benefit solutions, to transform how employees understand and use their health plans
- JIADE, a provider of education support services for adult education institutions through its subsidiaries in the Peoples Republic of China, partnered with Chinalink Education Group, an education brand specializing in AI-empowered educational and cultural exchange program
Really big financings:
Healthtech:
- Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people living with cancer using its Helicon TM peptide platform to drug historically undruggable targets, raised a $305 million Series F financing co-led by RA Capital Management, Fidelity Management & Research Company and Janus Henderson Investors, with participation from new investors including Frazier Life Sciences, Soleus Capital, and a life science-dedicated investment fund. There was also strong participation from existing investors, including venBio Partners, Cormorant Asset Management, Nextech Invest, ARCH Venture Partners, Milky Way Investments, GV, accounts advised by T. Rowe Price Associates, Inc., Marshall Wace, General Catalyst, Invus, Farallon Capital Management, Foresite Capital, Rock Springs Capital, HBM Healthcare, Samsara BioCapital, Catalio Capital Management, Sixty Degree Capital, Alderline Group and others
- Soley Therapeutics, a drug discovery and development company using cells to uncover first-in-class medicines, raised a $200 million Series C financing led by Surveyor Capital, joined by HRTG Partners, RWN Management, and others. Existing investors, including Doug Leone Family Fund, Breyer Capital, and GordonMD Global Investments LP, and other undisclosed investors also participated
- EpiBiologics, a developer of tissue-selective extracellular protein degradation, raised a $107 million Series B financing co-led by GV and Johnson & Johnson. Novartis Venture Fund, Aulis Capital, Avego BioScience Capital, and Samsara BioCapital joined as new investors. In addition to GV, existing investors Polaris Partners, Digitalis Ventures, Taiho Ventures, Vivo Capital, Codon Capital, and Mission BioCapital participated in the round
- Rakuten Medical, a global biotechnology company developing and commercializing its Alluminox platform-based photoimmunotherapy, raised a $100 million Series F financing round led by TaiAx Life Science Fund L.P., and included Daiwa Securities, Mitsui Sumitomo Insurance, Sumitomo Mitsui Banking, ABIES Capital and Nexus CVC. Strategic partner OEP Group also joined, along with existing investors, including SBI Group, Rakuten Group, Inc. and Mickey Mikitani
Big financings:
Healthtech:
- Topos Bio, a biotechnology company pioneering AI-driven drug discovery for intrinsically disordered proteins, raised $10.5 million in seed funding from Boldstart, Threshold, and Neo, with participation from notable angel investors including Dara Khosrowshahi (CEO of Uber) and Naveen Rao
- Canopy, a connected safety platform for U.S. health systems, raised a $22 million Series B funding round led by 111° West Capital and ACME Capital and joined by all of Canopy’s existing investors
- Pomelo Care, a provider of evidence-based healthcare for women and children, raised $92 million in Series C funding led by Stripes with participation from Andreessen Horowitz, PLUS Capital, Atomico, BoxGroup, and SV Angel
- Apella, developer of an ambient video intelligence platform providing hospitals with real-time operational intelligence, raised $80 million in a Series B round led by HighlandX, with returning investors Vensana Capital, Casdin Capital, PFM Health Sciences, Upside Partnership, and Operator Partners, and including new investors K2 HealthVentures, OpAmp Capital, and Houston Methodist
- Mediar Therapeutics, a clinical-stage biotechnology company advancing therapies designed to halt fibrosis, raised a $76 million Series B financing co-led by Amplitude Ventures and ICG, with participation from new investors Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust, and existing Series A investors
- Beacon Therapeutics, a clinical-stage biotechnology company with a mission to save and restore vision in people with rare and prevalent ocular diseases, raised over $75 million in a Series C financing led by Life Sciences at Goldman Sachs Alternatives and with participation from the Retinal Degeneration Fund. Beacon’s existing investors, Syncona Limited, Forbion, Oxford Science Enterprises, and Advent Life Sciences, also participated in the round
- Poplar Therapeutics, a clinical-stage immunology company developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions, raised a $50 million Series A financing led by SR One, Vida Ventures and Platanus
- Vizgen, a provider of spatial multi-omics platforms enabling researchers to reveal cellular insights through spatial transcriptomics proteomics, raised a $48 million financing led by ARCH Venture Partners and co-led by M Ventures and Northpond Ventures with participation from the company’s existing investors
- Ukko, a biotechnology company re-inventing immunotherapy for allergic diseases, raised a $45M series C financing led by Israel Biotech Fund, with participation from Khosla Ventures, Leaps by Bayer, Fall Line Capital, and Sanara Capital, among others
- FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, raised a €35 million Series C financing round from new investors, including Groupe Pasteur Mutualité and Groupe Etchart, alongside significant participation from the European Innovation Council’s EIB fund. Existing investors FH Founders, Lurra, IRDI, Groupe Doliam and NACO, also participated
- Bactolife, a biotechnology company that develops biological solutions to support gut health, raised over company specializing in the development of innovative solutions for cardiology, raised a €30 million in its Series B investment round led by Cross Border Impact Ventures and EIFO, alongside continued support from existing investors Novo Holdings and Athos
- Enable Injections, a healthcare innovation company developing and manufacturing the enFuse On-Body Delivery System, raised $30 million from Sanofi
- Engitix a biotech company targeting the extracellular matrix to develop transformative therapies for cancer and fibrosis, raised a $25 million Series A from Netherton Investments
- Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, raised $25 million in a round co-led by Elaia, Pfizer Ventures and Bpifrance, with participation from Wallonie Entreprendre, Argobio Studio, MACSF, The Institut Pasteur, InvestSud, Sambrinvest and Mission BioCapital
- Nocion Therapeutics, a biopharmaceutical company developing novel small molecule CSCBs selectively affect actively firing nociceptors for the treatment of serious conditions involving cough, itch, and pain, raised $23 million from existing investors led by Arkin Bio Capital and Monograph Capital, with participation from BioInnovation Capital, Canaan Partners, F-Prime Capital, Lumira Ventures, Mass General Brigham Ventures, Mission BioCapital, Morningside, Osage University Partners, and an undisclosed Strategic Investor
- Luminate, a healthcare technology company which helps patients to receive cancer treatments at home, raised $21 million in an expanded Series A round co-led by ARTIS Ventures and Lachy Groom with participation from Western Alliance Life Sciences alongside existing investors 8VC, Y Combinator, Atlantic Bridge, Faber, SciFounders, and others
- Even Healthcare, a managed-care startup, raised $20 million from Lachy Groom and Alpha Wave
- Tucuvi, a provider of Clinical Voice AI for care management, raised $20 million in a Series A funding round led by Cathay Innovation and Leadwind, with participation from existing investors Frontline Ventures, Seaya Ventures, and Shilling
- ViCentra, a medical device company commercializing the Kaleido insulin patch pump system, raised $13 million from ROM Utrecht Region and a consortium of Dutch investors, including Venturing Tech, alongside increased support from existing investor Innovation Industries
- BrightHeart, a provider of AI solutions for prenatal ultrasound, raised an €11 million Series A financing round co-led by Odyssée Venture and GO Capital, with participation from the Mussallem CHD Alliance, Lift Value, IDAHO HealthTech Club via Side Angels, and founding investor Sofinnova Partners, as well as clinicians and angel investors, including Professor Laurent Salomon, Sacha Loiseau and John Gridley
Edtech:
- Cloudforce, an AI firm looking to democratize safe, equitable AI in education, healthcare, and beyond, raised a $10 million Series A funding round led by Owl Ventures, with participation from M12
Not so big financings:
Healthtech:
- Carna Health, a digital health company revolutionizing kidney care, raised $8 million from Dr. Jay Rosan, Cenk Bekmezçi, Jose Pereyra, Mark Boulding, Brandon Salomon, Andrew Roosevelt, Jeff Lindsey, Joseph White, John Brooks, Elvis Ndansi and Dr. Salvatore Viscomi
- Oasys Health, an AI-native operating system for behavioral health, raised $4.6 million in funding, including a $4M seed round led by Pathlight Ventures, with participation from Twine Ventures and Better Ventures, and $600K in pre-seed funding from 1984 Ventures
- Kinotek, a movement health analytics company, raised $2 million in post-seed equity funding from Maine Venture Fund
Edtech:
- Artificial intelligence-powered learning platform Luca raised an $8 million Series A round led by 6 Degrees Capital, with participation from Explorer, Heartcore Capital and Shilling VC
Fund News
- Eir Partners, a private equity firm focused on health tech and tech-enabled services, closed its third fund, Eir Partners III, with $1 billion in capital commitments
Policy and government
- The U.S. Department of Labor announced the availability of $98 million in funding to support the development of pre-apprenticeships in high-demand industries including construction, advanced manufacturing, information technology, and healthcare. Funded through the department’s YouthBuild Program, the grants will help provide academic support, occupational skills training and employment services to young people, ages 16 to 24, in communities where many youths are not participating in the labor force
- The Centers for Disease Control and Prevention announced an overhaul of the childhood vaccine schedule that recommends fewer shots to all children. Under the change — effective immediately — the vaccine schedule will more closely resemble Denmark’s, recommending all children get vaccines for 11 diseases, compared with the 18 previously on the schedule
